[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES8602652A1 - Procedimiento para la preparacion de n-piridilindoles - Google Patents

Procedimiento para la preparacion de n-piridilindoles

Info

Publication number
ES8602652A1
ES8602652A1 ES532572A ES532572A ES8602652A1 ES 8602652 A1 ES8602652 A1 ES 8602652A1 ES 532572 A ES532572 A ES 532572A ES 532572 A ES532572 A ES 532572A ES 8602652 A1 ES8602652 A1 ES 8602652A1
Authority
ES
Spain
Prior art keywords
pyridyl
alkylene
lower alkyl
indole
substd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532572A
Other languages
English (en)
Other versions
ES532572A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES532572A0 publication Critical patent/ES532572A0/es
Publication of ES8602652A1 publication Critical patent/ES8602652A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE N-PIRIDILINDOLES.PREPARACION DE N-PIRIDILINDOLES DE FORMULA GENERAL (I) DONDE AR ES UN RADICALPIRIDILO O PIRIDILO SUBSTITUIDO POR ALQUILO INFERIOR, R1 ES HIDROGENO, HALOGENO, ALQUILO INFERIOR O ALQUILO SUSTITUIDO; P ES 1 O 2; R2 ES HIDROGENO O ALQUILO INFERIOR. UNO DE R3 Y R4 ES HIDROGENO Y EL OTRO DE R3 Y R4 ES UN GRUPO A-B DONDE A PUEDE SER ALQUILO O ALQUILO SUSTITUIDO Y B ALQUILO SUSTITUIDO O HETEROCICLO, CUYO PROCEDIMIENTO CONSISTE EN CICLAR UN COMPUESTO DE FORMULA GENERAL (VIII) DONDE R(1-4); P, AR TIENEN EL SIGNIFICADO ANTES DEFINIDO.DE APLICACION FARMACOLOGICA EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES COMO EL INFARTO, LA ANGINA DE PECHO Y LA HIPERTENSION.
ES532572A 1983-05-17 1984-05-17 Procedimiento para la preparacion de n-piridilindoles Expired ES8602652A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/495,370 US4536505A (en) 1983-05-17 1983-05-17 Certain N-(pyridyl) indoles

Publications (2)

Publication Number Publication Date
ES532572A0 ES532572A0 (es) 1985-12-01
ES8602652A1 true ES8602652A1 (es) 1985-12-01

Family

ID=23968377

Family Applications (5)

Application Number Title Priority Date Filing Date
ES532572A Expired ES8602652A1 (es) 1983-05-17 1984-05-17 Procedimiento para la preparacion de n-piridilindoles
ES545151A Expired ES8604195A1 (es) 1983-05-17 1985-07-12 Procedimiento para la preparacion de n-piridilindoles
ES545153A Expired ES8604197A1 (es) 1983-05-17 1985-07-12 Procedimiento para la preparacion de n-piridilindoles
ES545154A Expired ES8604922A1 (es) 1983-05-17 1985-07-12 Procedimiento para la preparacion de n-piridilindoles
ES545152A Expired ES8604196A1 (es) 1983-05-17 1985-07-12 Procedimiento para la preparacion de n-piridilindoles

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES545151A Expired ES8604195A1 (es) 1983-05-17 1985-07-12 Procedimiento para la preparacion de n-piridilindoles
ES545153A Expired ES8604197A1 (es) 1983-05-17 1985-07-12 Procedimiento para la preparacion de n-piridilindoles
ES545154A Expired ES8604922A1 (es) 1983-05-17 1985-07-12 Procedimiento para la preparacion de n-piridilindoles
ES545152A Expired ES8604196A1 (es) 1983-05-17 1985-07-12 Procedimiento para la preparacion de n-piridilindoles

Country Status (15)

Country Link
US (1) US4536505A (es)
EP (1) EP0126401A1 (es)
JP (1) JPS59212489A (es)
KR (1) KR840009302A (es)
AU (1) AU2809484A (es)
DD (1) DD224588A5 (es)
DK (1) DK242484A (es)
ES (5) ES8602652A1 (es)
FI (1) FI841925A (es)
GR (1) GR79934B (es)
HU (1) HUT34182A (es)
IL (1) IL71832A0 (es)
NO (1) NO841958L (es)
PT (1) PT78582A (es)
ZA (1) ZA843677B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675332A (en) * 1984-12-10 1987-06-23 Warner-Lambert Company Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
US4758586A (en) * 1985-02-01 1988-07-19 Usv Pharmaceutical Corp. Indolyl compounds and hyposensitivity use thereof
US4880822A (en) * 1987-04-24 1989-11-14 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyridinyl)-1H-indol-1-amines
US5039811A (en) * 1987-04-24 1991-08-13 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-(pyridinyl)-1H-indol-1-amines
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US5550118A (en) * 1994-01-31 1996-08-27 Eli Lilly And Company Polyhydronorharman synthase inhibitors
US5977125A (en) * 1994-10-31 1999-11-02 Eisai Co., Ltd. Mono-or polyenic carboxylic acid derivatives
GB2295151B (en) * 1994-11-18 1998-12-09 Nmc Polymerization of substituted heterocyclic monomers
ES2270585T3 (es) * 1998-02-23 2007-04-01 South Alabama Medical Science Foundation Acidos indol-3-propionico, sales y esteres de los mismos utilizados como medicamentos.
WO2003027101A1 (en) * 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation Substituted 3-pyridyl pyrroles and 3-pyridyl pyrazoles as c17,20 lyase inhibitors
BRPI0617271A2 (pt) * 2005-10-11 2011-07-19 Intermune Inc inibidores de replicação viral
KR100807718B1 (ko) * 2006-10-17 2008-02-28 한국생명공학연구원 인돌 유도체를 유효성분으로 함유하는 대사성 질환 예방 및치료용 약학적 조성물
CA2676906A1 (en) * 2007-02-12 2008-08-21 Intermune, Inc. Novel inhibitors hepatitis c virus replication
KR20090125799A (ko) * 2007-03-29 2009-12-07 아스비오파마 가부시키가이샤 Ｃｐｌａ2 저해 활성을 가지는 인돌 유도체 및 그 용도 및 제조 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449348A (en) * 1968-01-08 1969-06-10 Merck & Co Inc Alpha-halomethyl-1-pyridine or quinoline carbonyl-3-indolylacetic acids
AT299938B (de) * 1971-02-03 1972-07-10 Italiana Sint Spa Verfahren zur Herstellung des neuen Natriumsalzes der (1-Nicotinoyl-2-methyl-5-methoxy-3-indolyl)-essigsäure, gegebenenfalls im Gemisch mit der freien Säure
FR2171937A1 (en) * 1972-02-16 1973-09-28 Clin Midy Aminoketo indoles - analgesics and antidepressants
FR2171936B1 (es) * 1972-02-16 1975-04-25 Clin Midy
AT323154B (de) * 1973-02-02 1975-06-25 Hurka Wilhelm Verfahren zur herstellung von neuen 5-methoxy-2-methylindol-3-essigsäurederivaten sowie von deren salzen
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives
US4363912A (en) * 1980-12-15 1982-12-14 Pfizer Inc. Indole thromboxane synthetase inhibitors
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
GB2102795A (en) * 1981-07-31 1983-02-09 Pfizer Ltd Indole derivatives
US4460777A (en) * 1981-11-19 1984-07-17 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles

Also Published As

Publication number Publication date
HUT34182A (en) 1985-02-28
DK242484D0 (da) 1984-05-16
EP0126401A1 (de) 1984-11-28
ES8604922A1 (es) 1986-02-16
ES8604195A1 (es) 1986-01-16
ES8604197A1 (es) 1986-01-16
GR79934B (es) 1984-10-31
AU2809484A (en) 1984-11-22
ES8604196A1 (es) 1986-01-16
ZA843677B (en) 1985-02-27
ES545151A0 (es) 1986-01-16
JPS59212489A (ja) 1984-12-01
PT78582A (en) 1984-06-01
DK242484A (da) 1984-11-18
ES545154A0 (es) 1986-02-16
DD224588A5 (de) 1985-07-10
NO841958L (no) 1984-11-19
ES545153A0 (es) 1986-01-16
ES545152A0 (es) 1986-01-16
IL71832A0 (en) 1984-09-30
FI841925A (fi) 1984-11-18
FI841925A0 (fi) 1984-05-14
KR840009302A (ko) 1984-12-26
ES532572A0 (es) 1985-12-01
US4536505A (en) 1985-08-20

Similar Documents

Publication Publication Date Title
ES8604922A1 (es) Procedimiento para la preparacion de n-piridilindoles
NZ334476A (en) substituted indol-3-yl glyoxylamides
MY131126A (en) Sulfonamides
PH31566A (en) Pyridine and pyridine n-oxide derivatives for diaryl methyl piperidines or piperazines and compositions and methods of use thereof.
AU7941691A (en) Antimigraine alkoxypyrimidine derivatives
ES8304569A1 (es) Un procedimiento para la preparacion de una sal soluble en agua de lisina o arginina del 1,1-dioxido de n-(2-piridil)-2-metil-4-hidroxi-2h-1,2-benzotiazin-3-carboxamida.
TR200001799T2 (tr) Müstahzar olarak 5-(4-(2-(n-metil-n-(2-pirildil) mino)etoksi)benzil) tiyazolidin,-2,4-diyon, maleik asit tuzu, hidratı.
ES455800A1 (es) Procedimiento de preparacion de nuevos derivados de pirimi- dina.
ES8607953A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina
DE60226441D1 (de) Tetrahydrochinolinderivatverbindung und die verbindung als wirkstoff enthaltendes arzneimittel
AU3271289A (en) 3-substituted-2-oxindole-1-carboxamides for suppressing t-cell function
PH21301A (en) N-(1,8-naphthyridin--yl) amides and their pharmaceutical use
GB9419318D0 (en) Therapeutic agents
IL97054A0 (en) Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas
DE3265616D1 (en) Cephalosporin derivatives, their preparation and pharmaceutical compositions containing them
GR3021003T3 (en) Antineoplastic effect potentiator and antineoplastic agent
JO1164B1 (en) A process for preparing useful pyrimidone derivatives as useful 2-antihistamines
ES8701712A1 (es) Un procedimiento para la preparacion de una forma polimorfo i de una sal de monoetanolamina
HU896631D0 (en) Process for the preparation of novel indan derivatives
IE41135L (en) Tetrazole derivatives.
IT1255467B (it) Ammidi acriliche farmacologicamente attive
IT8248610A0 (it) Prodotto farmaceutico in polvere per la terapia dell'ulcera peptica, a base di 2,4-diammino-6-(2,5-diclo rofenil)-1,3,5-triazina o dei suoi sali farmaceuticamente accettabili
NZ309498A (en) 2-substituted benzyl-benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
GB1535778A (en) Compounds useful in treatment of unipolar depression
AU7314391A (en) Herbicidal pyridine derivatives and their salts of 3-(aminooxoacetyl)-2-(2-imidazolin-2-yl)